FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Invention represents a wide-spectrum vaccine against avian reovirus that is effective in target birds to reduce infection with avian reovirus. Vaccine contains an antigenic material obtained from reoviruses of two genotypic groups: 1 and 4, according to invention.
EFFECT: this vaccine is effective against all avian reoviruses, homologous or heterologous in relation to a vaccine, including virulent breakthrough strains of last time.
9 cl, 6 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AVIAN REOVIRUS STRAIN, VACCINE COMPRISING INDICATED REOVIRUS, METHOD FOR PREPARING AVIAN REOVIRUSES, METHOD FOR PREPARING VACCINE AND METHOD FOR CONTROL OF AVIAN PATHOLOGY CAUSED BY AVIAN REOVIRUSES | 2000 |
|
RU2265659C2 |
| VACCINES BASED ON REOVIRUSES | 2015 |
|
RU2708316C2 |
| VACCINES BASED ON REOVIRUS | 2015 |
|
RU2724497C2 |
| NEW AVIAN ASTROVIRUS | 2009 |
|
RU2547589C2 |
| RECOMBINANT HVT VECTORS EXPRESSING BIRD PATHOGENS ANTIGENS AND THEIR APPLICATION | 2012 |
|
RU2620936C2 |
| ASSOCIATED INACTIVATED NEWCASTLE DISEASE, INFECTIOUS BRONCHITIS, EGG DROP SYNDROME 76, INFECTIOUS BURSAL DISEASE AND REOVIRUS TENOSYNOVITIS EMULSION VACCINE | 2010 |
|
RU2443429C2 |
| NEWCASTLE DISEASE VIRUS "VNIIZZH G7" STRAIN FOR PRODUCTION OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF NEWCASTLE DISEASE OF BIRDS | 2024 |
|
RU2821028C1 |
| RECOMBINANT HVT-VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND VACCINES CONTAINING THESE VECTORS | 2017 |
|
RU2752836C2 |
| YAMAL STRAIN OF AVIAN INFLUENZA VIRUS OF ALPHAINFLUENZAVIRUS GENUS OF INFLUENZA A VIRUS SUBTYPE H5N1 SPECIES FOR THE MANUFACTURE OF BIOLOGICAL PRODUCTS FOR THE SPECIFIC PREVENTION OF AVIAN INFLUENZA TYPE A SUBTYPE H5 | 2022 |
|
RU2796987C1 |
| STRAIN "BG" OF AVIAN INFECTION BURSITIS VIRUS AND VACCINE AGAINST AVIAN INFECTION BURSITIS | 1997 |
|
RU2127602C1 |
